Primary |
Product Used For Unknown Indication |
29.4% |
Dementia Alzheimer's Type |
23.5% |
Dementia |
10.3% |
Parkinson's Disease |
5.9% |
Hypertension |
4.4% |
Myocardial Ischaemia |
4.4% |
Senile Dementia |
4.4% |
Cerebrovascular Accident |
2.9% |
Delirium |
2.9% |
Blood Cholesterol |
1.5% |
Blood Pressure |
1.5% |
Cerebral Small Vessel Ischaemic Disease |
1.5% |
Cognitive Disorder |
1.5% |
Depression |
1.5% |
Hallucination |
1.5% |
Hyperlipidaemia |
1.5% |
Memory Impairment |
1.5% |
|
Bradycardia |
12.5% |
Vomiting |
12.5% |
Rhabdomyolysis |
9.4% |
Social Avoidant Behaviour |
9.4% |
Hepatitis Toxic |
6.3% |
Toxic Skin Eruption |
6.3% |
Abdominal Wall Haemorrhage |
3.1% |
Dehydration |
3.1% |
Diarrhoea |
3.1% |
Drug Eruption |
3.1% |
Dyspnoea |
3.1% |
Dysstasia |
3.1% |
Electrocardiogram Qt Prolonged |
3.1% |
Freezing Phenomenon |
3.1% |
Incorrect Dose Administered |
3.1% |
Loss Of Consciousness |
3.1% |
Mobility Decreased |
3.1% |
Myocardial Ischaemia |
3.1% |
Panic Attack |
3.1% |
Psychomotor Hyperactivity |
3.1% |
|
Secondary |
Drug Use For Unknown Indication |
23.0% |
Dementia Alzheimer's Type |
10.3% |
Hypertension |
9.5% |
Atrial Fibrillation |
7.9% |
Dementia |
7.1% |
Sleep Disorder |
7.1% |
Ill-defined Disorder |
6.3% |
Product Used For Unknown Indication |
4.8% |
Memory Impairment |
4.0% |
Senile Dementia |
3.2% |
Agitation |
2.4% |
Delusion |
2.4% |
Parkinson's Disease |
2.4% |
Prophylaxis |
2.4% |
Chronic Lymphocytic Leukaemia |
1.6% |
Dementia Of The Alzheimer's Type, With Depressed Mood |
1.6% |
Major Depression |
1.6% |
Blood Cholesterol |
0.8% |
Cerebral Small Vessel Ischaemic Disease |
0.8% |
Depressed Mood |
0.8% |
|
Social Avoidant Behaviour |
15.0% |
Bradyarrhythmia |
10.0% |
Screaming |
10.0% |
Wheelchair User |
10.0% |
Subileus |
7.5% |
Dehydration |
5.0% |
Hepatitis Toxic |
5.0% |
Syncope |
5.0% |
White Blood Cell Count Increased |
5.0% |
Confusional State |
2.5% |
Diarrhoea |
2.5% |
Fall |
2.5% |
Headache |
2.5% |
Hyperhidrosis |
2.5% |
Hypertension |
2.5% |
Ileus |
2.5% |
Major Depression |
2.5% |
Motor Dysfunction |
2.5% |
Oxygen Saturation Decreased |
2.5% |
Respiratory Arrest |
2.5% |
|
Concomitant |
Drug Use For Unknown Indication |
18.6% |
Product Used For Unknown Indication |
10.2% |
Dementia |
7.8% |
Parkinson's Disease |
6.6% |
Depression |
6.0% |
Hypertension |
6.0% |
Pain |
5.4% |
Agitation |
4.8% |
Cardiac Disorder |
4.8% |
Insomnia |
4.2% |
Dementia Alzheimer's Type |
3.6% |
Staphylococcal Bacteraemia |
3.6% |
Vitamin Supplementation |
3.6% |
Blood Cholesterol |
3.0% |
Mineral Supplementation |
2.4% |
Osteoporosis |
2.4% |
Anxiety |
1.8% |
Huntington's Chorea |
1.8% |
Respiratory Disorder |
1.8% |
Rheumatoid Arthritis |
1.8% |
|
Renal Failure Acute |
10.8% |
Syncope |
8.1% |
Atrial Fibrillation |
5.4% |
Hepatic Encephalopathy |
5.4% |
Loss Of Consciousness |
5.4% |
Malaise |
5.4% |
Memory Impairment |
5.4% |
Neoplasm Malignant |
5.4% |
Palpitations |
5.4% |
Pleurothotonus |
5.4% |
Thrombocytopenia |
5.4% |
Varices Oesophageal |
5.4% |
Weight Increased |
5.4% |
Wound Infection |
5.4% |
Accidental Overdose |
2.7% |
Blood Urine Present |
2.7% |
Cardiac Pacemaker Insertion |
2.7% |
Cardiopulmonary Failure |
2.7% |
Cognitive Disorder |
2.7% |
Confusional State |
2.7% |
|